HopeStage
Back to all studies
CompletedNCT01651364

Cabergoline Compared With Placebo for Cocaine Cravings

About this titleRead the official source — NCT01651364
Medication studyAges 18–55United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 55 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2011
Recruitment status
Completed
Enrollment listed in the registry
11
Sponsor
Baylor College of Medicine
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT01651364
Official title
Show the full official title

A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Baylor College of Medicine, a university.

Did this study involve medication?

Yes. The study involved medication, including Placebo and Cabergoline.

Who was this study for?

Listed age limits: 18 years to 55 years.

Want to explore more studies?

Explore studies